Showing 61 - 80 results of 224 for search '"Pharmaceutical industry"', query time: 0.05s Refine Results
  1. 61

    EFFECT OF DICLOFENAС SODIUM ON MECHANISMS OF DIFFERENTIATION OF BONE MARROW CELLS AND PERIPHERAL BLOOD: A LITERATURE REVIEW by Yu. Bahmut, O. S. Ivanov, G. V. Tsapko

    Published 2018-12-01
    “…The hematopoietic system is a population of many cells that perform certain functions in the body. The pharmaceutical industry creates new drugs from the group of nonsteroidal anti-inflammatory drugs, but the “gold” standard remains the drug Diclofenac Sodium. …”
    Get full text
    Article
  2. 62

    Novel Method of Analysis for the Determination of Residual Formaldehyde by High-Performance Liquid Chromatography by Vittoria Delbono, Christopher P. Larch, Katrina Carol Newlands, Shona Rhydderch, Thomas Craven Baddeley, John Mervyn David Storey

    Published 2022-01-01
    “…Formaldehyde is commonly used as an alkylating agent in the pharmaceutical industry. Consequently, its residual level in drug substances and/or their intermediates needs to be accurately quantified. …”
    Get full text
    Article
  3. 63

    Improvement of N-Acetylcysteine Loaded in PLGA Nanoparticles by Nanoprecipitation Method by Ruth Lancheros, Carlos A. Guerrero, Rubén D. Godoy-Silva

    Published 2018-01-01
    “…However, its use in the pharmaceutical industry, as a proper specific load vehicle, still depends on the improvement of the load capacity.…”
    Get full text
    Article
  4. 64

    A proposed conceptual model for orphan drug market entry by Nataša Jalen, Tina Vukasović

    Published 2024-11-01
    “…Orphan drugs are developed by the pharmaceutical industry not for economic reasons, but to meet public health needs. …”
    Get full text
    Article
  5. 65

    Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics by Ramalingam Peraman, Kalva Bhadraya, Yiragamreddy Padmanabha Reddy

    Published 2015-01-01
    “…It is a current trend among pharmaceutical industry to implement analytical quality by design (AQbD) in method development process as a part of risk management, pharmaceutical development, and pharmaceutical quality system (ICH Q10). …”
    Get full text
    Article
  6. 66

    Data-based regression models for predicting remifentanil pharmacokinetics by Prathvi Shenoy, Mahadev Rao, Shreesha Chokkadi, Sushma Bhatnagar, Naveen Salins

    Published 2024-12-01
    “…Conclusion: Applying ML algorithms in drug delivery can significantly reduce resource costs and the time and effort essential for laboratory experiments in the pharmaceutical industry.…”
    Get full text
    Article
  7. 67

    FACTORS AFFECTING CONSUMER-BASED BRAND EQUITY OF VIETNAMESE PHARMACEUTICAL COMPANIES by Nguyễn Cao Quỳnh Tú, Lưu Tiến Dũng

    Published 2018-07-01
    “…Particularly in the pharmaceutical industry where products are directly related to human health, buying products of famous pharmaceutical brands to help ensure the lowest risk is gradually becoming a habit of consumers. …”
    Get full text
    Article
  8. 68

    Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology by Mafalda Jesus, Ana P. J. Martins, Eugenia Gallardo, Samuel Silvestre

    Published 2016-01-01
    “…This bioactive phytochemical not only is used as an important starting material for the preparation of several steroidal drugs in the pharmaceutical industry, but has revealed also high potential and interest in the treatment of various types of disorders such as cancer, hypercholesterolemia, inflammation, and several types of infections. …”
    Get full text
    Article
  9. 69

    Parallel Simulation of Population Balance Model-Based Particulate Processes Using Multicore CPUs and GPUs by Anuj V. Prakash, Anwesha Chaudhury, Rohit Ramachandran

    Published 2013-01-01
    “…Computer-aided modeling and simulation are a crucial step in developing, integrating, and optimizing unit operations and subsequently the entire processes in the chemical/pharmaceutical industry. This study details two methods of reducing the computational time to solve complex process models, namely, the population balance model which given the source terms can be very computationally intensive. …”
    Get full text
    Article
  10. 70

    Optimisation of food grade mixed surfactant‐based l‐ascorbic acid nanoemulsions using response surface methodology by Tahir Mehmood

    Published 2021-05-01
    “…These results may provide valuable contributions for food and pharmaceutical industry to develop delivery system for food additives and nutraceutical components.…”
    Get full text
    Article
  11. 71

    VI NHÂN GIỐNG CÂY ĐẲNG SÂM (CODONOPSIS JAVANICA) by Nguyễn Văn Kết

    Published 2014-09-01
    “…These initial results as a basis for further research on Codonopsis javanica Blume to the supply of raw materials for pharmaceutical industry in short term, high yield, regardless of the nature, and reduce price.…”
    Get full text
    Article
  12. 72

    One-step hydrothermal fabrication of AgInS2/SnIn4S8 nanocomposite with enhanced visible-light-activated photocatalytic activity by Zhong Fei, Zhu Zong Qiang

    Published 2025-01-01
    “…AgInS2/SnIn4S8 composites not only can degrade 2NP and tetracycline, but also had good mineralization efficiency for pharmaceutical industry wastewater.…”
    Get full text
    Article
  13. 73

    Choice of Innovative Technologies as a Factor of Modernization of the Industrial Plants by E. A. Panfilova

    Published 2015-04-01
    “…The research is based on in-depth interviews with experts from the pharmaceutical industry aimed at identifying the factors influencing the decision to purchase an innovative high-quality imported equipments and machinery, which would contribute to the modernization of the existing production process. …”
    Get full text
    Article
  14. 74

    Understanding the impact of triazoles on female fertility and embryo development: Mechanisms and implications by Sonal Sharma, Geeta Pandey

    Published 2025-06-01
    “…Triazoles are also frequently used in the pharmaceutical industry to treat fungal and bacterial infections as well as to treat and prevent some forms of pneumonia. …”
    Get full text
    Article
  15. 75

    Photostability and Photostabilization of Drugs and Drug Products by Iqbal Ahmad, Sofia Ahmed, Zubair Anwar, Muhammad Ali Sheraz, Marek Sikorski

    Published 2016-01-01
    “…Photostability studies of drugs and drug products are an integral part of the product development process in the pharmaceutical industry. These studies are carried out to ensure quality, efficacy, and safety of the formulated products during manufacture, storage, and use. …”
    Get full text
    Article
  16. 76

    Purification of crude turpentine oil through acid degumming using phosphoric acid by Sisdikarini Dana, Sulistiawati Endah, Hakika Dhias Cahya, Sulistyo Hary

    Published 2024-01-01
    “…One way to produce raw materials for the pharmaceutical industry is by utilizing waste from turpentine condensate. …”
    Get full text
    Article
  17. 77

    Patient and Physician Perspectives of Diabetic Retinopathy and Diabetic Macular Edema Diagnosis, Treatment and Progression: A Podcast Article by Daniel Newman, Bernadette Warren, Randall Barker, Charles C. Wykoff, Stela Vujosevic

    Published 2024-11-01
    “…The challenges of a DR diagnosis can be compounded by communication gaps that exist between patients, physicians, and the pharmaceutical industry. Development of new therapies is currently informed mainly by physician perspectives. …”
    Get full text
    Article
  18. 78

    Computational Perspectives into Plasmepsins Structure—Function Relationship: Implications to Inhibitors Design by Alejandro Gil L., Pedro A. Valiente, Pedro G. Pascutti, Tirso Pons

    Published 2011-01-01
    “…The development of efficient and selective antimalariais remains a challenge for the pharmaceutical industry. The aspartic proteases plasmepsins, whose inhibition leads to parasite death, are classified as targets for the design of potent drugs. …”
    Get full text
    Article
  19. 79

    The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need by Pierre-Alexandre Dionne, Farzad Ali, Mendel Grobler

    Published 2016-10-01
    “…New discoveries are a critical priority for the pharmaceutical industry. However, the use of fixed incremental cost-effectiveness (ICER) thresholds for health technology assessment (HTA) may compromise incentives to innovate and affect future treatment options. …”
    Get full text
    Article
  20. 80

    An HPLC-based Assay to Study the Activity of Cyclic Diadenosine Monophosphate (C-di-AMP) Synthase DisA from Mycobacterium smegmatis by Avisek Mahapa, Sudhanshu Gautam, Arti Rathore, Dipankar Chatterji

    Published 2024-12-01
    “…Because of its pivotal role in bacterial signaling and host immune response, this molecule has garnered significant interest from the pharmaceutical industry. This protocol outlines the quantification of c-di-AMP by an HPLC-based assay to enumerate the activity of c-di-AMP synthase from Mycobacterium smegmatis. …”
    Get full text
    Article